{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:11:00Z","timestamp":1791421860793,"version":"4.3.3"},"reference-count":42,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"3\/4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,2]]},"DOI":"10.14745\/ccdr.v43i34a01","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T10:11:50Z","timestamp":1518689510000},"page":"62-66","source":"Crossref","is-referenced-by-count":238,"title":["Latent tuberculosis infection: An overview"],"prefix":"10.14745","volume":"43","author":[{"given":"S","family":"Kiazyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TB","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5795","published-online":{"date-parts":[[2017,3,2]]},"reference":[{"key":"key20180215101147_r1","unstructured":"World Health Organization. Global tuberculosis report 2016. Geneva: WHO; 2016. Available from: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"key20180215101147_r2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.","volume":"7","year":"2009","journal-title":"Nat Rev Microbiol."},{"key":"key20180215101147_r3"},{"key":"key20180215101147_r4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination.","volume":"34","year":"2013","journal-title":"Annu Rev Public Health."},{"key":"key20180215101147_r5","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: WHO; 2015. Available from: http:\/\/www.who.int\/tb\/publications\/latent-tuberculosis-infection\/en\/."},{"key":"key20180215101147_r6","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling.","volume":"13","year":"2016","journal-title":"PLoS Med."},{"key":"key20180215101147_r7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","article-title":"The prognosis of a positive tuberculin reaction in childhood and adolescence.","volume":"99","year":"1974","journal-title":"Am J Epidemiol."},{"key":"key20180215101147_r8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection.","volume":"119","year":"1997","journal-title":"Epidemiol Infect."},{"key":"key20180215101147_r9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.","volume":"179","year":"2014","journal-title":"Am J Epidemiol."},{"key":"key20180215101147_r10","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection.","volume":"372","year":"2015","journal-title":"N Engl J Med."},{"key":"key20180215101147_r11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.","volume":"320","year":"1989","journal-title":"N Engl J Med."},{"key":"key20180215101147_r12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.","volume":"21","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"key20180215101147_r13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/COH.0b013e32832c7d61","article-title":"Epidemiology of HIV-associated tuberculosis.","volume":"4","year":"2009","journal-title":"Curr Opin HIV AIDS."},{"key":"key20180215101147_r14","unstructured":"Canadian Tuberculosis Standards, 7th ed. Ottawa: Public Health Agency of Canada; 2014. p. 1-468. Available from: http:\/\/www.phac-aspc.gc.ca\/tbpc-latb\/pubs\/tb-canada-7\/index-eng.php."},{"key":"key20180215101147_r15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2369-10-36","article-title":"Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial.","volume":"10","year":"2009","journal-title":"BMC Nephrol."},{"key":"key20180215101147_r16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/TP.0000000000000133","article-title":"Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period.","volume":"98","year":"2014","journal-title":"Transplantation."},{"issue":"5","key":"key20180215101147_r17","first-page":"474","article-title":"Silica, silicosis and tuberculosis.","volume":"11","year":"2007","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"key20180215101147_r18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/BOR.0b013e3283025ec2","article-title":"Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies.","volume":"20","year":"2008","journal-title":"Curr Opin Rheumatol."},{"key":"key20180215101147_r19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis.","volume":"55","year":"2006","journal-title":"Arthritis Rheum."},{"key":"key20180215101147_r20","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.","volume":"5","year":"2008","journal-title":"PLoS Med."},{"key":"key20180215101147_r21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-9-450","article-title":"The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review.","volume":"9","year":"2009","journal-title":"BMC Public Health."},{"issue":"11","key":"key20180215101147_r22","first-page":"942","article-title":"Smoking and tuberculosis: an association overlooked.","volume":"6","year":"2002","journal-title":"Int J Tuberc Lung Dis."},{"key":"key20180215101147_r23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ije\/dyp308","article-title":"A consistent log-linear relationship between tuberculosis incidence and body mass index.","volume":"39","year":"2010","journal-title":"Int J Epidemiol."},{"issue":"10","key":"key20180215101147_r24","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","year":"1999","journal-title":"Int J Tuberc Lung Dis."},{"key":"key20180215101147_r25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1440-1843.2010.01751.x","article-title":"Treatment of latent tuberculosis infection: an update.","volume":"15","year":"2010","journal-title":"Respirology."},{"key":"key20180215101147_r26","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection.","volume":"365","year":"2011","journal-title":"N Engl J Med."},{"issue":"3","key":"key20180215101147_r27","first-page":"67","article-title":"A shorter treatment regimen for latent tuberculosis infection holds promise for at-risk Canadians.","volume":"43","year":"2017","journal-title":"Can Commun Dis Rep."},{"key":"key20180215101147_r28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.","volume":"27","year":"2014","journal-title":"Clin Microbiol Rev."},{"key":"key20180215101147_r29","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0140-6736(10)60359-5","article-title":"Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice.","volume":"375","year":"2010","journal-title":"Lancet."},{"key":"key20180215101147_r30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.","volume":"56","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"key20180215101147_r31","doi-asserted-by":"crossref","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis.","volume":"7","year":"2012","journal-title":"PLoS One."},{"issue":"5","key":"key20180215101147_r32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/TP.0000000000000451","article-title":"The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis.","volume":"99","year":"2015","journal-title":"Transplantation."},{"key":"key20180215101147_r33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1183\/13993003.01464-2015","article-title":"Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection.","volume":"47","year":"2016","journal-title":"Eur Respir J."},{"issue":"5","key":"key20180215101147_r34","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.","volume":"48","year":"2016","journal-title":"Eur Respir J."},{"key":"key20180215101147_r35","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-\u03b3 horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis.","volume":"43","year":"2014","journal-title":"Eur Respir J."},{"key":"key20180215101147_r36","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/infdis\/jiu803","article-title":"Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.","volume":"211","year":"2015","journal-title":"J Infect Dis."},{"issue":"10035","key":"key20180215101147_r37","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"ACS and GC6-74 cohort study groups. A blood RNA signature for tuberculosis disease risk: a prospective cohort study.","volume":"387","year":"2016","journal-title":"Lancet."},{"key":"key20180215101147_r38"},{"issue":"4","key":"key20180215101147_r39","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards TB elimination: an action framework for low-incidence countries.","volume":"45","year":"2015","journal-title":"Eur Respir J."},{"key":"key20180215101147_r40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's Global TB Programme. WHO's new end TB strategy.","volume":"385","year":"2015","journal-title":"Lancet."},{"key":"key20180215101147_r41","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.","volume":"46","year":"2015","journal-title":"Eur Respir J."},{"key":"key20180215101147_r42","unstructured":"Tuberculosis prevention and control in Canada: a federal framework for action. Ottawa: Public Health Agency of Canada; 2014. p. 1-14. Available from: http:\/\/www.phac-aspc.gc.ca\/tbpc-latb\/pubs\/tpc-pct\/index-eng.php."}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/17vol43\/dr-rm43-3-4\/assets\/pdf\/17vol43_3_4-ar-01-eng.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T21:40:56Z","timestamp":1570743656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/17vol43\/dr-rm43-3-4\/assets\/pdf\/17vol43_3_4-ar-01-eng.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":42,"journal-issue":{"issue":"3\/4","published-online":{"date-parts":[[2017,3,2]]},"published-print":{"date-parts":[[2017,3,2]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v43i34a01","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}